Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma

Published:2022-11-23 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Hui Caressa,Wu Yufan (Fred),Liu Kevin,Sandhu Navjot,Blomain Erik,Binkley Michael S,Gephart Melanie H,Chang Steven D.,Li Gordon H,Reddy Sunil A,Soltys Scott G,Pollom Erqi

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference31 articles.

1. Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort;Iorgulescu JB;Cancer Immunol Res,2018

2. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman PB;N Engl J Med,2011

3. Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma;Ascierto PA;J Clin Oncol,2013

4. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild A;Lancet,2012

5. Improved survival with MEK inhibition in BRAF-mutated melanoma;Flaherty KT;N Engl J Med,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent Radiation and Targeted Therapy for Papillary Craniopharyngioma: A Case Report;Cureus;2023-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP